Selected research
Industry Research
Pharmacovigilance (PV) Outsourcing Industry Research Report 2026
Market perspective
The global Pharmacovigilance (PV) Outsourcing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmacovigilance (PV) Outsourcing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmacovigilance (PV) Outsourcing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmacovigilance (PV) Outsourcing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmacovigilance (PV) Outsourcing include Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation and iMED Global Corporation, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmacovigilance (PV) Outsourcing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmacovigilance (PV) Outsourcing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmacovigilance (PV) Outsourcing Market by Company
Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen
Novartis
Pharmacovigilance (PV) Outsourcing Segment by Type
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)
Pharmacovigilance (PV) Outsourcing Segment by Application
Premarketing Clinical Trial
Post-marketing Clinical Practice
Other
Pharmacovigilance (PV) Outsourcing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance (PV) Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance (PV) Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance (PV) Outsourcing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmacovigilance (PV) Outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Contract Research Organizations (CROs)
- Business Process Outsourcing (BPOs)
Applications
- Premarketing Clinical Trial
- Post-marketing Clinical Practice
- Other
Companies covered
- Accenture
- C3i Solutions
- Clintec
- Covance
- Deloitte Touche Tohmatsu Limited
- ELC Group
- Ergomed
- iGATE Corporation
- iMED Global Corporation
- IQVIA
- MarksMan Healthcare
- Medpace Holdings
- Oracle Corporation
- Parexel
- PharmInvent
- PrimeVigilance
- Pure Drug Safety
- Sciformix
- SIRO Clinpharm
- Symogen
- Novartis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmacovigilance (PV) Outsourcing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Contract Research Organizations (CROs)
- 2.2.3 Business Process Outsourcing (BPOs)
- 2.3 Pharmacovigilance (PV) Outsourcing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Premarketing Clinical Trial
- 2.3.3 Post-marketing Clinical Practice
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Pharmacovigilance (PV) Outsourcing Breakdown Data by Type
- 3.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2027-2032)
4 Pharmacovigilance (PV) Outsourcing Breakdown Data by Application
- 4.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmacovigilance (PV) Outsourcing Market Perspective (2021-2032)
- 5.2 Global Pharmacovigilance (PV) Outsourcing Growth Trends by Region
- 5.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmacovigilance (PV) Outsourcing Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmacovigilance (PV) Outsourcing Market Dynamics
- 5.3.1 Pharmacovigilance (PV) Outsourcing Industry Trends
- 5.3.2 Pharmacovigilance (PV) Outsourcing Market Drivers
- 5.3.3 Pharmacovigilance (PV) Outsourcing Market Challenges
- 5.3.4 Pharmacovigilance (PV) Outsourcing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue
- 6.1.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue (2021-2026)
- 6.1.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmacovigilance (PV) Outsourcing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmacovigilance (PV) Outsourcing Head Office and Area Served
- 6.4 Global Pharmacovigilance (PV) Outsourcing Players, Product Type & Application
- 6.5 Global Pharmacovigilance (PV) Outsourcing Manufacturers Established Date
- 6.6 Global Pharmacovigilance (PV) Outsourcing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmacovigilance (PV) Outsourcing Market Size (2021-2032)
- 7.2 North America Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
- 7.4 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmacovigilance (PV) Outsourcing Market Size (2021-2032)
- 8.2 Europe Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
- 8.4 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmacovigilance (PV) Outsourcing Market Size (2021-2032)
- 10.2 South America Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
- 10.4 South America Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Accenture
- 12.1.1 Accenture Company Information
- 12.1.2 Accenture Business Overview
- 12.1.3 Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.1.4 Accenture Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.1.5 Accenture Recent Developments
- 12.2 C3i Solutions
- 12.2.1 C3i Solutions Company Information
- 12.2.2 C3i Solutions Business Overview
- 12.2.3 C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.2.4 C3i Solutions Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.2.5 C3i Solutions Recent Developments
- 12.3 Clintec
- 12.3.1 Clintec Company Information
- 12.3.2 Clintec Business Overview
- 12.3.3 Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.3.4 Clintec Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.3.5 Clintec Recent Developments
- 12.4 Covance
- 12.4.1 Covance Company Information
- 12.4.2 Covance Business Overview
- 12.4.3 Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.4.4 Covance Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.4.5 Covance Recent Developments
- 12.5 Deloitte Touche Tohmatsu Limited
- 12.5.1 Deloitte Touche Tohmatsu Limited Company Information
- 12.5.2 Deloitte Touche Tohmatsu Limited Business Overview
- 12.5.3 Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.5.4 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.5.5 Deloitte Touche Tohmatsu Limited Recent Developments
- 12.6 ELC Group
- 12.6.1 ELC Group Company Information
- 12.6.2 ELC Group Business Overview
- 12.6.3 ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.6.4 ELC Group Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.6.5 ELC Group Recent Developments
- 12.7 Ergomed
- 12.7.1 Ergomed Company Information
- 12.7.2 Ergomed Business Overview
- 12.7.3 Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.7.4 Ergomed Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.7.5 Ergomed Recent Developments
- 12.8 iGATE Corporation
- 12.8.1 iGATE Corporation Company Information
- 12.8.2 iGATE Corporation Business Overview
- 12.8.3 iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.8.4 iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.8.5 iGATE Corporation Recent Developments
- 12.9 iMED Global Corporation
- 12.9.1 iMED Global Corporation Company Information
- 12.9.2 iMED Global Corporation Business Overview
- 12.9.3 iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.9.4 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.9.5 iMED Global Corporation Recent Developments
- 12.10 IQVIA
- 12.10.1 IQVIA Company Information
- 12.10.2 IQVIA Business Overview
- 12.10.3 IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.10.4 IQVIA Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.10.5 IQVIA Recent Developments
- 12.11 MarksMan Healthcare
- 12.11.1 MarksMan Healthcare Company Information
- 12.11.2 MarksMan Healthcare Business Overview
- 12.11.3 MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.11.4 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.11.5 MarksMan Healthcare Recent Developments
- 12.12 Medpace Holdings
- 12.12.1 Medpace Holdings Company Information
- 12.12.2 Medpace Holdings Business Overview
- 12.12.3 Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.12.4 Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.12.5 Medpace Holdings Recent Developments
- 12.13 Oracle Corporation
- 12.13.1 Oracle Corporation Company Information
- 12.13.2 Oracle Corporation Business Overview
- 12.13.3 Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.13.4 Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.13.5 Oracle Corporation Recent Developments
- 12.14 Parexel
- 12.14.1 Parexel Company Information
- 12.14.2 Parexel Business Overview
- 12.14.3 Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.14.4 Parexel Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.14.5 Parexel Recent Developments
- 12.15 PharmInvent
- 12.15.1 PharmInvent Company Information
- 12.15.2 PharmInvent Business Overview
- 12.15.3 PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.15.4 PharmInvent Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.15.5 PharmInvent Recent Developments
- 12.16 PrimeVigilance
- 12.16.1 PrimeVigilance Company Information
- 12.16.2 PrimeVigilance Business Overview
- 12.16.3 PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.16.4 PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.16.5 PrimeVigilance Recent Developments
- 12.17 Pure Drug Safety
- 12.17.1 Pure Drug Safety Company Information
- 12.17.2 Pure Drug Safety Business Overview
- 12.17.3 Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.17.4 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.17.5 Pure Drug Safety Recent Developments
- 12.18 Sciformix
- 12.18.1 Sciformix Company Information
- 12.18.2 Sciformix Business Overview
- 12.18.3 Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.18.4 Sciformix Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.18.5 Sciformix Recent Developments
- 12.19 SIRO Clinpharm
- 12.19.1 SIRO Clinpharm Company Information
- 12.19.2 SIRO Clinpharm Business Overview
- 12.19.3 SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.19.4 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.19.5 SIRO Clinpharm Recent Developments
- 12.20 Symogen
- 12.20.1 Symogen Company Information
- 12.20.2 Symogen Business Overview
- 12.20.3 Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.20.4 Symogen Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.20.5 Symogen Recent Developments
- 12.21 Novartis
- 12.21.1 Novartis Company Information
- 12.21.2 Novartis Business Overview
- 12.21.3 Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2021-2026)
- 12.21.4 Novartis Pharmacovigilance (PV) Outsourcing Product Portfolio
- 12.21.5 Novartis Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst